Design Therapeutics, Inc.DSGNNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank83
3Y CAGR+13.2%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
+13.2%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthElevated
PeriodValueYoY Change
20252.53+75.5%
20241.44+169.9%
20230.53-69.4%
20221.75-32.2%
20212.57+102.6%
2020-99.70+67.8%
2019-309.75-